Table 1

Baseline characteristics of the identified study cohort of type 2 diabetes, by full dataset and by training and validation cohortsdatasets

CharacteristicsFull datasetTraining datasetValidation dataset
Patient count, n (%)139 626111 748 (80)27 878 (20)
Age, years±SD63.0±12.563.0±12.563.1±12.6
Gender (female), n (%)62 168 (44.5)49 686 (44.5)12 482 (44.8)
Number of general practices400400396
Mean baseline HbA1c,% (mmol/mol±SD)*7.8 (62±22)7.8 (62±22)7.8 (62±22)
Cases with HbA1c data, n (%)122 294 (88)97 858 (88)24 436 (88)
Ethnicity, n (%)
 White116 393 (83.4)93 157 (83.4)23 236 (83.3)
 Non-White11 024 (7.9)8842 (7.9)2182 (7.8)
 Unknown12 209 (8.7)9749 (8.7)2460 (8.8)
IMD quintiles, n (%)
 Quintile 1 (affluent)26 930 (19.3)21 437 (19.2)5493 (19.7)
 Quintile 229 534 (21.1)23 580 (21.1)5954 (21.4)
 Quintile 329 539 (21.1)23 742 (21.2)5797 (20.8)
 Quintile 427 883 (20.0)22 341 (20.0)5542 (19.9)
 Quintile 5 (deprived)25 641 (18.4)20 571 (18.4)5070 (18.2)
 Unknown99 (0.1)77 (0.1)22 (0.1)
Mean follow-up, years±SD7.6±4.87.6±4.77.6±4.8
Region in England, n (%)
 North East3202 (2.3)2560 (2.3)642 (2.3)
 North West24 115 (17.3)19 412 (17.4)4703 (16.9)
 Yorkshire and the Humber6036 (4.3)4799 (4.3)1237 (4.4)
 East Midlands4553 (3.3)3660 (3.3)893 (3.2)
 West Midlands17 838 (12.8)14 252 (12.8)3586 (12.9)
 East of England14 540 (10.4)11 573 (10.4)2967 (10.6)
 South West18 658 (13.4)14 888 (13.3)3770 (13.5)
 South Central15 617 (11.2)12 441 (11.1)3176 (11.4)
 London17 250 (12.4)13 829 (12.4)3421 (12.3)
 South East Coast17 817 (12.8)14 334 (12.8)3483 (12.5)
  • *Most recent measure within 1 year before or 6 months after index date.

  • HbA1c, glycated hemoglobin; IMD, Index of Multiple Deprivation.